Fresenius | FRE - Interest Expense On Debt


Fresenius reported EUR81M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Akzo Nobel EUR 68M 26M Jun/2025
Alcon AG USD 52M 2M Mar/2026
AstraZeneca USD 340M 144M Jun/2026
BASF EUR 236M 15M Dec/2025
Bayer EUR 675M 87M Dec/2025
Beiersdorf EUR 7.5M 19.5M Jun/2025
DaVita Healthcare Partners USD 17.71B 210.12M Jun/2026
Demant DKK 398M 37M Dec/2025
E.ON EUR 543M 7M Dec/2025
Essilor EUR 168M 21M Dec/2025
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 79M 6M Mar/2026
Getinge SEK 133M 31M Jun/2026
Givaudan CHF 58M 7M Dec/2025
GlaxoSmithKline GBP 121M 46M Jun/2026
GN Store Nord DKK 296M 42M Dec/2025
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Lonza CHF 84M 14M Jun/2025
Merck EUR 104M 17M Mar/2026
Novartis USD 462M 119M Jun/2026
Philips EUR 83M 26M Mar/2026
Roche Holding CHF 304M 7.5M Jun/2025
RWE EUR 138M 214M Dec/2025
Sanofi EUR 287M 109M Jun/2026
Smith & Nephew USD 69M 1000K Dec/2025